[Localized amyloidosis of upper respiratory tract].
[On amyloidosis of the upper respiratory tract].
Localized amyloidosis of the orbit and upper respiratory tract.
Amyloidosis of the Upper Aerodigestive Tract: Management of a Rare Disease and Review of the Literature.
Send T, Spiegel JL, Schade G, Pantelis A, Olthoff A, Bootz F, Canis M, Jakob M.
Dysphagia. 2019 Apr;34(2):179-191. doi: 10.1007/s00455-018-9956-x. Epub 2018 Oct 31.
[Tumor-like amyloidosis of the upper respiratory tract].
Bykova VP, Daikhes NA, Platonova GA, Bakhtin AA, Kornienko KA, Romanenko SG, Nazhmudinov II.
Arkh Patol. 2019;81(5):74-79. doi: 10.17116/patol20198105174.
Secondary amyloidosis of the conjunctiva and mucosa of upper respiratory tract associated with renal cell carcinoma: case report and review of literature.
Ibrahim TM, Iheonunekwu N.
Niger J Med. 2009 Apr-Jun;18(2):172-4.
Localized Amyloidosis of the Upper Aerodigestive Tract: Complex Analysis of the Cellular Infiltrate and the Amyloid Mass.
Turiak L, Kaszás B, Katona K, Lacza Á, Márk L, Vékey K, Drahos L, Tornóczky T.
Anal Cell Pathol (Amst). 2019 Aug 19;2019:6165140. doi: 10.1155/2019/6165140. eCollection 2019.
Localized amyloidosis of the head and neck and upper aerodigestive and lower respiratory tracts.
Simpson GT 2nd, Strong MS, Skinner M, Cohen AS.
Ann Otol Rhinol Laryngol. 1984 Jul-Aug;93(4 Pt 1):374-9. doi: 10.1177/000348948409300418.
Amyloidosis of the upper aerodigestive tract.
Pribitkin E, Friedman O, O'Hara B, Cunnane MF, Levi D, Rosen M, Keane WM, Sataloff RT.
Laryngoscope. 2003 Dec;113(12):2095-101. doi: 10.1097/00005537-200312000-00007.
[Amyloidosis in larynx].
Greves SL, Philipsen BB, Lange B.
Ugeskr Laeger. 2018 Jul 16;180(29):V12170923.
Combined amyloidosis of the upper and lower respiratory tract.
Schulz C, Hauck RW, Nathrath WB, Präuer HW, Linke RP, Emslander HP.
Respiration. 1995;62(3):163-6. doi: 10.1159/000196415.
Isatuximab plus carfilzomib-dexamethasone versus carfilzomib-dexamethasone in patients with relapsed multiple myeloma (IKEMA): overall survival analysis of a phase 3, randomised, controlled trial.
Yong K, Martin T, Dimopoulos MA, Mikhael J, Capra M, Facon T, Hajek R, Špička I, Baker R, Kim K, Martinez G, Min CK, Pour L, Leleu X, Oriol A, Koh Y, Suzuki K, Casca F, Macé S, Risse ML, Moreau P.
Lancet Haematol. 2024 Oct;11(10):e741-e750. doi: 10.1016/S2352-3026(24)00148-0. Epub 2024 Jul 24.
Patisiran for the treatment of hereditary transthyretin-mediated amyloidosis.
Yang J.
Expert Rev Clin Pharmacol. 2019 Feb;12(2):95-99. doi: 10.1080/17512433.2019.1567326. Epub 2019 Jan 18.
